Treatment led to tumor regression and dense immune infiltrate, including many CD4+ and CD8+ cells, in both treated and untreated lesions, some at distant sites which would be consistent with the generation of a tumor specific systemic immune response [29]. Here, CD8A is linked to neoplasm.